![](/us.svg)
Trademark: 97069693
Word
FROM NEUTRON TO PATIENT
Status Date
Wednesday, April 3, 2024
Filing Date
Tuesday, October 12, 2021
Published for Opposition
Tuesday, February 28, 2023
5 Pharmaceutical preparations for the diagnosis and treatment of cancer and tumors; pharmaceutical preparations for the diagnosis and treatment of oncological diseases; radioactive pharmaceutical substances for use in nuclear medicine, intended for medical treatments and imaging; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
42 Pharmaceutical research and development services; providing medical research information in the fields of pharmaceuticals, oncology and nuclear medicine
Apr 3, 2024
Sou Extension 2 Granted
Apr 3, 2024
Sou Extension 2 Filed
Apr 3, 2024
Sou Teas Extension Received
Mar 12, 2024
Teas Change Of Correspondence Received
Mar 12, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 12, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 27, 2023
Notice Of Approval Of Extension Request E-Mailed
Oct 25, 2023
Sou Extension 1 Granted
Oct 25, 2023
Sou Extension 1 Filed
Oct 25, 2023
Sou Teas Extension Received
Apr 25, 2023
Noa E-Mailed - Sou Required From Applicant
Feb 28, 2023
Official Gazette Publication Confirmation E-Mailed
Feb 28, 2023
Published For Opposition
Feb 8, 2023
Notification Of Notice Of Publication E-Mailed
Jan 26, 2023
Approved For Pub - Principal Register
Jan 24, 2023
Teas/Email Correspondence Entered
Jan 23, 2023
Correspondence Received In Law Office
Jan 23, 2023
Teas Response To Office Action Received
Jul 22, 2022
Notification Of Non-Final Action E-Mailed
Jul 22, 2022
Non-Final Action E-Mailed
Jul 22, 2022
Non-Final Action Written
Jul 18, 2022
Assigned To Examiner
Jun 7, 2022
Teas Change Of Correspondence Received
Jun 7, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 7, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 2, 2021
New Application Office Supplied Data Entered
Oct 15, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24